Data source
ATTRV-PN
Data for this study are from the NEURO-TTR trial, a phase 3, multinational, multicenter, randomized, placebo-controlled, double-blinded study of inotersen for the treatment of ATTRv-PN (ClinicalTrials.gov ID: NCT01737398) [